about
Vaccination for hepatitis C virus: closing in on an evasive targetSuperHapten: a comprehensive database for small immunogenic compoundsImmunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzeesGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignQuantification of viral infection dynamics in animal experimentsSystems biology applied to vaccine and immunotherapy developmentHepatitis C virus and vaccine developmentThe phantom menace.Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infectionHuman combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virusEssential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle AssemblyInduction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus StrainRole of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and ReplicationIn vitro selection of a neutralization-resistant hepatitis C virus escape mutantSang Froid in a time of trouble: is a vaccine against HIV possible?Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goatsStructure–activity relationship studies on anti-HCV activity of ring-expanded (‘fat’) nucleobase analogues containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring systemStructural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1Hepatitis C Virus E2 Envelope Glycoprotein Core StructureElucidation of hepatitis C virus transmission and early diversification by single genome sequencingICTV Virus Taxonomy Profile: FlaviviridaeCandidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunitiesImmunotherapy for HCV infection: next steps.Immunogenomics and systems biology of vaccines.Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfectionPotential impact of vaccination on the hepatitis C virus epidemic in injection drug users.Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal modelsThe hepatitis C virus E1 glycoprotein undergoes productive folding but accelerated degradation when expressed as an individual subunit in CHO cells.Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.Treatment of hepatitis C virus infectionDevelopment of hepatitis C virus vaccines: challenges and progress.Characterization of Anti-HCV Antibodies in IL-10-Treated PatientsToo much of a good thing? When to stop catch-up vaccinationEffect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes.Hepatitis C virus: current concepts and future challenges.New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy.Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccineVaccination with dendritic cells pulsed with hepatitis C pseudo particles induces specific immune responses in mice.
P2860
Q22305922-52648A3D-F447-47DC-91D8-7BEDC1097E87Q24675503-AE637702-5235-4B39-955F-EA625D80861CQ24685256-BA70DD4E-BFD4-47AD-A22B-16CD854F6E71Q26801759-6F6483FE-EA48-477F-93B0-B84053E4B940Q26824804-919FA039-D45D-4670-B757-2C013B7E5A97Q26830374-9871FFB8-DCF9-445F-A907-D124BD03FA11Q27001610-CC747B52-EDC0-41FD-A94A-BA697ECD5A27Q27472943-1FCE4D35-1800-429E-B1D5-A0DB13028312Q27481055-52EEE618-34DC-49A9-A890-D7216B3C1DF9Q27481388-D3923C17-A668-4F64-A051-3B48D5043BB7Q27485487-05CC7AC2-DC8D-4840-831D-CACCEF04590CQ27486582-66C688F9-DA37-42CD-9B0F-8476D0F6C125Q27486778-AC85C51C-5DA6-4381-9AA4-1D7C3F687DAFQ27487337-FC206533-39DC-49A2-B85D-26E33CCAC23EQ27487549-F5FF65BF-C4E6-4EF3-88A4-A02F3B591790Q27487961-8320A5F5-D2A2-4351-B53B-BF03ED5FF0B8Q27488724-691968E7-4912-43E3-A40E-BA5BE6C72412Q27488832-3A566BB5-EF28-43D9-ACE1-B07022B0BCB0Q27679280-BB07B774-B579-4363-9EAF-F5DAB0EC55A9Q27680704-11D71682-D0C6-4DC1-9DE1-935C6637B310Q28482493-06AFFC77-9B2C-4745-9671-4F26C287C0E5Q28828638-2CE9E0B8-A8A9-44D8-9806-3C14DA0032B5Q30226978-EB1684C1-CD54-40DC-A092-5CEF91A5258FQ30371832-FC5C61D2-D5EF-4C69-AB1E-340C0A516732Q33350387-54B1F4EB-C6C1-43AA-B2DF-6CAE73BB01F0Q33650138-D160F797-2C47-4833-B6D5-836F4949FEC4Q33824723-770D1FD6-0830-4F2A-B8CD-76C3C6D66E95Q33826033-4FF7554E-EFE6-44A1-A2B4-9277AC825EA4Q33867634-E5D6B738-07D4-42CD-A70D-E8D4C3A24C76Q34000089-16CF164C-A363-4FF4-A29B-F67D63ECFF38Q34072573-92FB78D5-C932-4AA5-8EF5-120A10C8CAD6Q34099424-1907950A-6B65-48E0-8913-E662F03ABE01Q34254941-D3933AF9-85AE-43BE-83B7-E028C3250B37Q34296870-BADD1E3D-A557-4EAE-A92C-D9E1E05BB4BBQ34585496-8AA570D4-1465-4462-818B-363805AA0DBEQ35576891-AD045033-8371-429D-8C03-061230FFD00AQ35606162-C6AC091D-9134-4759-B7CC-F9DF928B5D78Q35653358-27C4415E-0F51-42DC-8CE9-DC3E342C763DQ35771272-95AE15CC-3003-4250-AF34-2D5BE990787AQ35776114-085445EE-159D-434B-8934-7E5B35ACC4C9
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prospects for a vaccine against the hepatitis C virus.
@ast
Prospects for a vaccine against the hepatitis C virus.
@en
type
label
Prospects for a vaccine against the hepatitis C virus.
@ast
Prospects for a vaccine against the hepatitis C virus.
@en
prefLabel
Prospects for a vaccine against the hepatitis C virus.
@ast
Prospects for a vaccine against the hepatitis C virus.
@en
P2860
P356
P1433
P1476
Prospects for a vaccine against the hepatitis C virus.
@en
P2093
Michael Houghton
P2860
P2888
P304
P356
10.1038/NATURE04081
P407
P577
2005-08-01T00:00:00Z
P6179
1001937936